Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances.
We tested the hypothesis that anthracycline-induced cardiac and renal damage is mediated by vasoactive substances. A 1-minute exposure to 5 micrograms per ml. of doxorubicin (DXR, Adriamycin) produced cardiac histamine release in isolated rabbit hearts. Under conditions in which histamine uptake and metabolism were impaired, the administration of DXR, 2 mg. per kg., over 1 minute was associated with elevations in arterial histamine and catecholamines. The chronic weekly administration of DXR produced severe cardiac and renal damage. The administration of combined histaminic and adrenergic blockade with diphenhydramine, cimetidine, phentolamine, and propranolol (DCPP) pre- and immediately post-DXR resulted in near total protection against DXR-mediated cardiac damage and prevented the majority of the renal lesions. The combined administration of diphenhydramine, cimetidine, phentolamine, and propranolol did not appear to be acting by mechanisms other than blockade of vasoactive amine receptors as cardiac uptake of DXR and the DXR antitumor response were not altered by diphenhydramine, cimetidine, phentolamine, and propranolol. This study demonstrates that anthracycline-associated cardiac and renal toxicity may be mediated by vasoactive substances and that anthracycline cardiomyopathy is potentially preventable.
D000818:Animals; D001158:Arteries; D009202:Cardiomyopathies / Q000139:chemically induced*; D002395:Catecholamines / Q000097:blood; D004317:Doxorubicin / Q000009:adverse effects* / Q000378:metabolism; D005260:Female; D006633:Histamine Antagonists / Q000494:pharmacology; D006636:Histamine Release; D007674:Kidney Diseases / Q000139:chemically induced*; D009206:Myocardium / Q000378:metabolism; D011817:Rabbits; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D002395:Catecholamines; D006633:Histamine Antagonists; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D004317:Doxorubicin